IVERIC bio, Inc. (NASDAQ:ISEE – Get Rating) was the target of a large increase in short interest in the month of May. As of May 31st, there was short interest totalling 15,070,000 shares, an increase of 27.2% from the May 15th total of 11,850,000 shares. Based on an average daily volume of 3,700,000 shares, the […]
StockNews.com assumed coverage on shares of IVERIC bio (NASDAQ:ISEE – Get Rating) in a research note published on Monday. The brokerage issued a sell rating on the stock. Other equities analysts have also issued reports about the company. Credit Suisse Group lowered IVERIC bio from an outperform rating to a neutral rating in a report […]
StockNews.com assumed coverage on shares of IVERIC bio (NASDAQ:ISEE – Get Rating) in a report published on Monday morning. The firm issued a sell rating on the stock. ISEE has been the topic of several other reports. HC Wainwright lowered IVERIC bio from a buy rating to a neutral rating in a research report on […]
Eversept Partners LP purchased a new stake in shares of IVERIC bio, Inc. (NASDAQ:ISEE – Get Rating) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 350,747 shares of the company’s stock, valued at approximately $7,509,000. Eversept Partners LP owned 0.29% […]
Boxer Capital LLC acquired a new position in IVERIC bio, Inc. (NASDAQ:ISEE – Get Rating) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 825,000 shares of the company’s stock, valued at approximately $17,663,000. Boxer Capital LLC owned 0.68% of IVERIC bio as of […]